Optimisation of Recombinant Myrosinase Production in Pichia pastoris.
Zuzana RosenbergováKristína KántorováMartin ŠimkovičAlbert BreierMartin RebrošPublished in: International journal of molecular sciences (2021)
Myrosinase is a plant defence enzyme catalysing the hydrolysis of glucosinolates, a group of plant secondary metabolites, to a range of volatile compounds. One of the products, isothiocyanates, proved to have neuroprotective and chemo-preventive properties, making myrosinase a pharmaceutically interesting enzyme. In this work, extracellular expression of TGG1 myrosinase from Arabidopsis thaliana in the Pichia pastoris KM71H (MutS) strain was upscaled to a 3 L laboratory fermenter for the first time. Fermentation conditions (temperature and pH) were optimised, which resulted in a threefold increase in myrosinase productivity compared to unoptimised fermentation conditions. Dry cell weight increased 1.5-fold, reaching 100.5 g/L without additional glycerol feeding. Overall, a specific productivity of 4.1 U/Lmedium/h was achieved, which was 102.5-fold higher compared to flask cultivations.
Keyphrases
- arabidopsis thaliana
- recombinant human
- climate change
- poor prognosis
- saccharomyces cerevisiae
- lactic acid
- ms ms
- body mass index
- single cell
- photodynamic therapy
- cell therapy
- physical activity
- weight loss
- stem cells
- mass spectrometry
- cancer therapy
- binding protein
- radiation therapy
- cerebral ischemia
- brain injury
- blood brain barrier
- rectal cancer
- subarachnoid hemorrhage
- gas chromatography